Bank of America
CRMD icon

Bank of America’s CorMedix CRMD Stock Holding History

Bank of America’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,000
Closed -$246K – 7286
2015
Q1 		$246K Buy
+5,000
New +$119K ﹤0.01% 4801

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America's CRMD Position: Q1 2026 in Review

Bank of America increased its CorMedix (CRMD) stake by 11% in Q1 2026, buying an estimated $105K and bringing the position to 144,835 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #4538.

Bank of America first reported a position in CRMD in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.31M in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Bank of America held 144,835 shares of CorMedix worth $983K as of Q1 2026.
  • Bank of America bought 14,266 CorMedix shares in Q1 2026, an estimated $105K.
  • CorMedix made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4538 holding.
  • Bank of America first reported a position in CorMedix in Q2 2013 and has held it in 48 quarters since.
  • Bank of America's CorMedix position peaked at $3.31M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.